These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

493 related items for PubMed ID: 24030871

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [The relationship of mTOR signaling pathway and histone acetylation in human gastric cancer cell lines].
    Sun DF, Fang JY, Zhang YJ, Tian XQ, Zhu HY, Li EL, Gu WQ, Shen GF.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug; 24(4):387-91. PubMed ID: 17680526
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Histone Deacetylase Inhibitors Inhibit the Proliferation of Gallbladder Carcinoma Cells by Suppressing AKT/mTOR Signaling.
    Zhang P, Guo Z, Wu Y, Hu R, Du J, He X, Jiao X, Zhu X.
    PLoS One; 2015 Aug; 10(8):e0136193. PubMed ID: 26287365
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma.
    Peponi E, Drakos E, Reyes G, Leventaki V, Rassidakis GZ, Medeiros LJ.
    Am J Pathol; 2006 Dec; 169(6):2171-80. PubMed ID: 17148679
    [Abstract] [Full Text] [Related]

  • 8. Effects of targeting endometrial stromal sarcoma cells via histone deacetylase and PI3K/AKT/mTOR signaling.
    Quan P, Moinfar F, Kufferath I, Absenger M, Kueznik T, Denk H, Zatloukal K, Haybaeck J.
    Anticancer Res; 2014 Jun; 34(6):2883-97. PubMed ID: 24922651
    [Abstract] [Full Text] [Related]

  • 9. Superior activity of a new histone deacetylase inhibitor (ZYJ-34c) in inhibiting growth of human leukemia cells by inducing p21WAF1 expression and cell cycle arrest.
    Yang H, Xu W, Li Y, Lan P, Zhang J, Zhang Y, Zhang C.
    Anticancer Drugs; 2014 Aug; 25(7):767-77. PubMed ID: 24686006
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of EGFR/PI3K/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells.
    Zhou C, Qiu L, Sun Y, Healey S, Wanebo H, Kouttab N, Di W, Yan B, Wan Y.
    Int J Oncol; 2006 Jul; 29(1):269-78. PubMed ID: 16773209
    [Abstract] [Full Text] [Related]

  • 11. Histone deacetylase inhibitors activate p21(WAF1) expression via ATM.
    Ju R, Muller MT.
    Cancer Res; 2003 Jun 01; 63(11):2891-7. PubMed ID: 12782595
    [Abstract] [Full Text] [Related]

  • 12. ERK inhibition enhances TSA-induced gastric cancer cell apoptosis via NF-κB-dependent and Notch-independent mechanism.
    Yao J, Qian CJ, Ye B, Zhang X, Liang Y.
    Life Sci; 2012 Sep 04; 91(5-6):186-93. PubMed ID: 22781708
    [Abstract] [Full Text] [Related]

  • 13. Phosphorylated 4E-binding protein 1 (p-4E-BP1): a novel prognostic marker in human astrocytomas.
    Korkolopoulou P, Levidou G, El-Habr EA, Piperi C, Adamopoulos C, Samaras V, Boviatsis E, Thymara I, Trigka EA, Sakellariou S, Kavantzas N, Patsouris E, Saetta AA.
    Histopathology; 2012 Aug 04; 61(2):293-305. PubMed ID: 22690797
    [Abstract] [Full Text] [Related]

  • 14. The histone deacetylase inhibitor trichostatin a decreases lymphangiogenesis by inducing apoptosis and cell cycle arrest via p21-dependent pathways.
    Hrgovic I, Doll M, Kleemann J, Wang XF, Zoeller N, Pinter A, Kippenberger S, Kaufmann R, Meissner M.
    BMC Cancer; 2016 Sep 30; 16(1):763. PubMed ID: 27716272
    [Abstract] [Full Text] [Related]

  • 15. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
    Korkolopoulou P, Levidou G, Trigka EA, Prekete N, Karlou M, Thymara I, Sakellariou S, Fragkou P, Isaiadis D, Pavlopoulos P, Patsouris E, Saetta AA.
    BJU Int; 2012 Dec 30; 110(11 Pt C):E1237-48. PubMed ID: 23107319
    [Abstract] [Full Text] [Related]

  • 16. Histone Deacetylase Inhibitor Trichostatin A Suppresses Cell Proliferation and Induces Apoptosis by Regulating the PI3K/AKT Signalling Pathway in Gastric Cancer Cells.
    An X, Wei Z, Ran B, Tian H, Gu H, Liu Y, Cui H, Zhu S.
    Anticancer Agents Med Chem; 2020 Dec 30; 20(17):2114-2124. PubMed ID: 32593284
    [Abstract] [Full Text] [Related]

  • 17. Trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and promotes apoptosis of esophageal squamous cell lines.
    Ma J, Guo X, Zhang S, Liu H, Lu J, Dong Z, Liu K, Ming L.
    Mol Med Rep; 2015 Jun 30; 11(6):4525-31. PubMed ID: 25634603
    [Abstract] [Full Text] [Related]

  • 18. Histone deacetylase inhibitor induces cell apoptosis and cycle arrest in lung cancer cells via mitochondrial injury and p53 up-acetylation.
    Bao L, Diao H, Dong N, Su X, Wang B, Mo Q, Yu H, Wang X, Chen C.
    Cell Biol Toxicol; 2016 Dec 30; 32(6):469-482. PubMed ID: 27423454
    [Abstract] [Full Text] [Related]

  • 19. Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway.
    Marzec M, Kasprzycka M, Liu X, El-Salem M, Halasa K, Raghunath PN, Bucki R, Wlodarski P, Wasik MA.
    Oncogene; 2007 Aug 16; 26(38):5606-14. PubMed ID: 17353907
    [Abstract] [Full Text] [Related]

  • 20. Concurrent inhibition of PI3-kinase and mTOR induces cell death in diffuse large B cell lymphomas, a mechanism involving down regulation of Mcl-1.
    Zang C, Eucker J, Liu H, Müller A, Possinger K, Scholz CW.
    Cancer Lett; 2013 Oct 10; 339(2):288-97. PubMed ID: 23200668
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.